StockData
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

MANGOCEUTICALS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.28−0.01 (-3.38%)

Close on Oct 19, 2026

Market cap
$4.80M
P/E (TTM)
–
Dividend yield
–

MANGOCEUTICALS, INC. revenue by segment

No segment breakdown reported

Mangoceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.